Koss Olinger Consulting, LLC Johnson & Johnson Transaction History

Koss Olinger Consulting, LLC

$1.14 Billion
Q3 2024

A detailed history of Koss Olinger Consulting, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Koss Olinger Consulting, LLC holds 5,434 shares of JNJ stock, worth $843,193. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,434

Previous 4,669 16.38%

Holding current value

$843,193

Previous $682,000 29.03%

% of portfolio

0.08%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$145.48 - $167.38 $111,292 - $128,045	765 Added 16.38%	5,434 $880,000
Q2 2024 Aug 06, 2024	BUY	$144.38 - $157.78 $674,110 - $736,674	4,669 New	4,669 $682,000
Q4 2023 Feb 13, 2024	BUY	$145.6 - $158.88 $807,934 - $881,625	5,549 New	5,549 $869,000
Q2 2023 Jul 28, 2023	SELL	$154.35 - $166.11 $10,495 - $11,295	-68 Reduced 1.01%	6,689 $1.11 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $580,032 - $692,198	3,840 Added 131.64%	6,757 $1.05 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $80,740 - $90,614	-504 Reduced 14.73%	2,917 $515,000
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $14,358 - $15,977	89 Added 2.67%	3,421 $559,000
Q2 2022 Jul 08, 2022	SELL	$168.19 - $186.01 $200,314 - $221,537	-1,191 Reduced 26.33%	3,332 $591,000
Q1 2022 May 06, 2022	SELL	$158.14 - $179.59 $107,535 - $122,121	-680 Reduced 13.07%	4,523 $802,000
Q4 2021 Feb 07, 2022	SELL	$155.93 - $173.01 $84,825 - $94,117	-544 Reduced 9.47%	5,203 $890,000
Q3 2021 Nov 09, 2021	SELL	$161.5 - $179.47 $588,667 - $654,168	-3,645 Reduced 38.81%	5,747 $928,000
Q2 2021 Aug 11, 2021	SELL	$159.48 - $171.07 $108,765 - $116,669	-682 Reduced 6.77%	9,392 $1.55 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $1.54 Million - $1.72 Million	10,074 New	10,074 $1.66 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Koss Olinger Consulting, LLC with notifications on news.

Account

Koss Olinger Consulting, LLC Johnson & Johnson Transaction History